Skip to main content
Improve Medical Instruments CO., Ltd. logo

Improve Medical Instruments CO., Ltd. — Investor Relations & Filings

Ticker · 300030 ISIN · CNE100000JL3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,954 across all filing types
Latest filing 2020-09-01 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300030

About Improve Medical Instruments CO., Ltd.

https://www.improve-medical.com

Improve Medical Instruments CO., Ltd. focuses on the development, production, and distribution of clinical laboratory and nursing solutions. The core product range includes evacuated blood collection systems, specimen collection and transport media, and laboratory automation equipment. The company also provides medical imaging components and point-of-care testing (POCT) systems. By integrating research and development with advanced manufacturing, the organization supports clinical diagnostics and patient care through high-precision tools designed for healthcare facilities and research laboratories. Its offerings are characterized by a commitment to diagnostic safety and efficiency across global markets.

Recent filings

Filing Released Lang Actions
第五届董事会第三次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a board meeting of Guangzhou Yangpu Medical Technology Co., Ltd. It details decisions related to a 2020 restricted stock incentive plan, including approval of the plan draft, management rules, and authorization requests to the shareholders' meeting. The document includes voting results and mentions that these matters will be submitted to the shareholders' meeting for approval. There are no financial statements or detailed financial data presented. The document is a board meeting resolution announcement, not a full management report or financial report. It is not a proxy statement or shareholder meeting notice but a board/management information announcement about internal governance decisions. Therefore, the appropriate classification is Board/Management Information (MANG). The document length is 3320 characters, which is consistent with a meeting resolution announcement rather than a full report.
2020-09-01 Chinese
2020年限制性股票激励计划自查表
Regulatory Filings Classification · 95% confidence The document is a detailed compliance self-inspection checklist related to a 2020 restricted stock incentive plan for Guangzhou Yangpu Medical Technology Co., Ltd. It includes numerous compliance questions about the stock incentive plan, its participants, legal and regulatory adherence, and internal approvals. The content focuses on the stock incentive plan's regulatory compliance and internal governance rather than financial results or audit opinions. It is not an annual report, audit report, earnings release, or any financial statement. It is also not a brief announcement or a presentation. The document is a regulatory compliance report related to stock incentive plans, which fits best under Regulatory Filings (RNS) as it does not match any other specific category such as Remuneration Information or Proxy Solicitation. The document length is under 5,000 characters, but it contains substantive compliance content rather than just an announcement of a report, so it is not a Report Publication Announcement (RPA). Therefore, the best classification is Regulatory Filings (RNS).
2020-09-01 Chinese
2020年限制性股票激励计划激励对象名单
Remuneration Information Classification · 95% confidence The document is a list of recipients for a 2020 restricted stock incentive plan, detailing the allocation of restricted shares to various executives and core management personnel. It includes names, positions, and share quantities. This type of document is related to executive compensation and stock incentive plans, which falls under remuneration information rather than a full annual report, earnings release, or management report. It is not a proxy solicitation or voting result announcement. The document length is short (1661 characters) and contains detailed allocation data, consistent with a remuneration information report.
2020-09-01 Chinese
关于子公司医疗器械产品延续注册的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the extension of the registration validity of a medical device product (medical protective masks) by a regulatory authority (Hunan Provincial Drug Administration). It details the product registration certificate number, validity period, classification, specifications, and intended use. The document emphasizes the impact on the company's future operations and advises investors to be cautious. There is no financial data, no mention of financial results, no detailed report or presentation, and no indication of a meeting or voting results. The document is an official regulatory announcement about product registration status, which fits best under Regulatory Filings (RNS) as it is a compliance-related disclosure that does not fit other specific categories.
2020-08-21 Chinese
关于授权公司管理层使用闲置资金投资固定收益类、承诺保本类及结构性存款产品的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from Guangzhou Yangpu Medical Technology Co., Ltd. regarding the authorization for company management to use idle funds to invest in fixed income, principal-guaranteed, and structured deposit products. It details the board meeting resolutions, investment purpose, risk control measures, and impact on daily operations. The document is a formal announcement of a financing-related decision but does not contain financial statements or detailed financial results. It is not a full financial report, earnings release, or management discussion. It is best classified as a Capital/Financing Update (CAP) because it relates to the company's capital usage and investment decisions involving idle funds.
2020-08-14 Chinese
关于披露2020年半年度报告的提示性公告
Report Publication Announcement Classification · 95% confidence The document is a short announcement (487 characters) about the disclosure of the company's 2020 half-year report. It states that the 2020 half-year report and its summary were approved and published on a regulatory website. The document does not contain the actual financial data or detailed report content but serves as a notification to investors to review the report elsewhere. According to the 'MENU VS MEAL' rule, such a brief notice about the report's publication is classified as a Report Publication Announcement (RPA), not the report itself (IR).
2020-08-14 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.